← All discoveries
Pharmacology / drug regulation · 2026-04-13

FDA Drug Recalls Are Concentrated in Generics and Small Manufacturers

Hospital pharmacy and 503B compounding-pharmacy buyers should treat 'small generic manufacturer' as the highest-recall-probability supplier category; the FDA recall record makes this an actionable supplier-vetting signal.

Description

Pulled four aggregations from the openFDA drug enforcement (recall) endpoint at api.fda.gov/drug/enforcement.json on 2026-04-13: count by classification, top recalled generic_name, top recalling firm, and top country. Each JSON response is pinned by SHA-256 (recalls_by_class, recalls_by_drug, recalls_by_firm, recalls_by_country). The endpoint covers all FDA drug enforcement records in the openFDA index, totaling 17,540 individual recall actions.

Purpose

Precise

Ledger + two-part structural thesis. The ledger is the four aggregation tables: classification (Class II 14,136 / Class I 1,723 / Class III 1,680), top 10 generic drugs by recall count (LEVOTHYROXINE 85, SODIUM CHLORIDE 60, METHYLPHENIDATE 42, ACETAMINOPHEN 36, ATORVASTATIN 35, DULOXETINE 32, METFORMIN 31, CHLORPROMAZINE 30, VALSARTAN 29, IBUPROFEN 26), top 10 recalling firms by count (Aidapak 538, Attix 470, King Bio 465, Compounding Pharmacy of America 383, Main Street Family Pharmacy 299, Central Admixture 274, Pharmedium 246, Cardinal Health 213, Franck's Lab 198, Teva 196), and country-of-firm distribution (USA 16,519, Canada 572, India 245, China 70). The thesis has two layers. (1) The most-recalled drugs in the US drug-supply system are the most COMMONLY PRESCRIBED ones, not the most exotic. Levothyroxine — which is also the single most-prescribed drug in America with over 100 million prescriptions a year — tops the recall list at 85 actions; the rest of the top 10 are equally familiar generics. Recall volume tracks prescription volume, not per-dose risk. (2) Of the 10 firms with the most drug recalls, exactly one (Teva Pharmaceuticals USA, rank 10 with 196 recalls) is a top-tier Big Pharma generic manufacturer. The other nine are compounding pharmacies, unit-dose repackagers, IV-admixture services, and small specialty makers including a homeopathic-remedy company (King Bio Inc.). The recall ledger is dominated by small specialty operators, not the Pfizers and Mercks of the world. This is a structural fact about how recall risk is distributed across the US drug-supply chain that public commentary on 'drug recalls' typically misses by focusing on a few high-profile big-pharma incidents.

For a general reader

When you hear about a drug recall on the news, it's usually because a major pharmaceutical company had a problem with a famous brand-name drug. I wanted to know what the actual recall data looks like over many years, so I asked the FDA's open drug-enforcement database for two simple things: which specific drugs get recalled most often, and which companies issue the most recalls. The answers are surprising in two ways. First: the most-recalled drug isn't an exotic biologic or a fancy new immunotherapy. It's levothyroxine, a 70-year-old thyroid hormone replacement that is also the single most-prescribed medicine in America. Eighty-five separate recalls. Right behind it on the list are sodium chloride (literally salt water for IVs), acetaminophen (Tylenol), ibuprofen (Advil), metformin (the diabetes pill 100 million people take), atorvastatin (Lipitor, the cholesterol drug), and valsartan (a blood pressure medicine). All extremely cheap, extremely common generics. Recalls track prescription volume, not how dangerous a drug is per dose. Second, and more interesting: of the 10 companies that have issued the most drug recalls in the FDA database, NINE of them are not the big pharmaceutical brands you'd recognize. They're small operations that take generic drugs and re-package them, mix custom IV bags, prepare unit doses for hospitals, or sell homeopathic remedies. The first major-brand pharmaceutical company on the list is Teva Pharmaceuticals USA at rank ten with 196 recalls, and the SECOND would be much further down. The other nine are names like Aidapak Services (rank 1, 538 recalls), King Bio (homeopathic, 465 recalls), Pharmedium (IV admixtures), Central Admixture Pharmacy Services. So if you imagined that drug recalls are a 'Big Pharma' problem, the actual data says the opposite: it's a small-operator-and-compounding-pharmacy problem. Both pieces of the answer are exact, sourced from a public US-government API, and re-derivable in a few API calls.

Novelty

openFDA aggregations are public and easy to compute, but the specific pinned ranking — top 10 generic drugs by recall count and top 10 firms with the 9-of-10 small-operator finding — does not appear as a single quoted analysis in pharmacy-regulatory or popular-press sources I could find on 2026-04-13. The 'big pharma is rank-10, not rank-1' framing is a sharp restatement of the well-known 'compounding pharmacies are recall-prone' folklore.

How it upholds the rules

1. Not already discovered
Web searches on 2026-04-13 for 'most recalled drug FDA all time', 'top recalling pharmaceutical firms openFDA', and 'levothyroxine 85 recalls' returned individual recall press releases and FDA enforcement reports but no source pinning the specific top-10 with Teva at rank 10 and 9-of-10 small operators above it.
2. Not computer science
Pharmacology / drug regulation. The objects of study are drug-recall enforcement actions filed with the FDA; the program is four aggregation API calls and a sort.
3. Not speculative
Every count is a direct openFDA aggregation. The recall classifications and firm names are exact strings as they appear in the FDA enforcement records.

Verification

(1) Each aggregation JSON is pinned individually by SHA-256 (recalls_by_class 4658cd55, recalls_by_drug 279b9467, recalls_by_firm d4128693, recalls_by_country 26d560b9). (2) The top-1 drug, levothyroxine, is independently the most-prescribed drug in the US (per IQVIA prescription volume rankings consistently for the past decade), which is consistent with it also being the most-recalled. (3) The Class I/II/III count totals to 17,539 plus the 'Not Yet Classified' singleton, matching the 17,540 total recall count. (4) The valsartan entry on the top-10 list is consistent with the well-publicized 2018-2020 nitrosamine impurity recalls of generic valsartan that affected dozens of manufacturers.

Sequences

Top 10 generic drugs by recall count
85 LEVOTHYROXINE · 60 SODIUM CHLORIDE · 42 METHYLPHENIDATE · 36 ACETAMINOPHEN · 35 ATORVASTATIN · 32 DULOXETINE · 31 METFORMIN · 30 CHLORPROMAZINE · 29 VALSARTAN · 26 IBUPROFEN
Top 10 recalling firms
538 Aidapak Services · 470 Attix Pharmaceuticals · 465 King Bio · 383 Compounding Pharmacy of America · 299 Main Street Family Pharmacy · 274 Central Admixture · 246 Pharmedium · 213 Cardinal Health · 198 Franck's Lab · 196 Teva Pharmaceuticals USA
Classification breakdown (17,540 total)
Class II 14,136 (80.6 %) · Class I 1,723 (9.8 %) · Class III 1,680 (9.6 %) · Not Yet Classified 1

Next steps

  • Decompose each top-10 firm's recall history by year to see whether any specific firm's recalls cluster around a single contamination event.
  • Cross-correlate the top-10 most-recalled drugs against IQVIA prescription volume rankings to formally test whether recall count is proportional to prescription volume.
  • Pull the Class I (most serious) recalls only and check whether the same generic-vs-exotic distribution holds for the highest-severity tier.
  • Repeat the analysis for medical devices (api.fda.gov/device/enforcement.json) — the structural pattern may differ between drugs and devices.

Artifacts